Jupiter Neurosciences, Inc. Common Stock (JUNS) Stock Analysis

Jupiter Neurosciences, Inc. Common Stock (JUNS) is a publicly traded company in the HEALTHCARE sector. It trades at $0.28, carries a market capitalization of $11.39M. This page summarizes the public market data, fundamentals, and frequently asked questions for JUNS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.28
• Market Cap: $11.39M
• EPS: $-0.26
• 52-Week High: $3.33
• 52-Week Low: $0.17

Market Sentiment

Jupiter Neurosciences, Inc. Common Stock currently has a Bullish sentiment score of 0.63.

About Jupiter Neurosciences, Inc. Common Stock

Jupiter Neurosciences, Inc. is a clinical-stage biotechnology company headquartered in Jupiter, Florida, specializing in the development of innovative pharmaceutical therapies targeting neuroinflammation-related disorders through its proprietary resveratrol platform. The company is focused on advancing its robust drug development pipeline, aimed at providing breakthrough treatments for various neurological conditions amid a growing demand for effective neurotherapeutics. With a strong commitm...

GNG Research Analysis

GNG Research scores Jupiter Neurosciences, Inc. Common Stock (JUNS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for JUNS.

Frequently Asked Questions

Does JUNS pay dividends?

Jupiter Neurosciences, Inc. Common Stock (JUNS) does not currently pay a regular dividend.

What is JUNS's market cap?

Jupiter Neurosciences, Inc. Common Stock (JUNS) has a market capitalization of $11.39M with a current stock price of $0.28.